ASTH-HR: Anxiety Sensitivity Treatment for Heroin Users

• Sponsor: University of Maryland (Other)
• Overall Status: Unknown status
• CT.gov ID: NCT01196312
• Collaborator: (none)
• Enrollment: 60
• Location: 1
• Duration (Months): 23
• Patients Per Site Per Month: 2.6

Study Details

Study Description

Brief Summary

Anxiety Sensitivity Treatment for Heroin Users is a development project targeting mild and above levels of anxiety sensitivity that will involve the testing of a specialized protocol for improving treatment retention and outcomes for heroin dependent individuals in a residential substance use treatment. ASTH-HR will integrate established treatment modules such as Healthy Relationships, along with interoceptive exposure, affect management, and psycho-education exercises developed for anxiety prevention and treatment programs with standard substance use treatment.

Condition or Disease	Intervention/Treatment	Phase
Anxiety	Behavioral: Anxiety sensitivity therapy	N/A

Study Design

• Study Type: Interventional
• Anticipated Enrollment: 60 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: None (Open Label)
• Primary Purpose: Treatment
• Official Title: Novel Intervention for Drug Use and HIV Risk Among Anxiety Sensitive Heroin Users
• Study Start Date: Oct 1, 2009
• Anticipated Primary Completion Date: Mar 1, 2011
• Anticipated Study Completion Date: Sep 1, 2011

Outcome Measures

Primary Outcome Measures

1. Anxiety Sensitivity Index-3 [24 weeks]

Secondary Outcome Measures

1. Timeline Follow Back 90 days [24 weeks]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 65 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• exhibit a score of 21 on a self-report measure of anxiety sensitivity

• be in 28 days of residential substance use treatment.

• meet criteria for current opioid dependence as determined by SCID interview administered at intake.

Exclusion Criteria:

• evidence of limited mental competency

• the inability to give informed, voluntary, written consent to participate

• current psychosis

• current bipolar disorder.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Salvation Army Harbor Light Treatment Facilitiy	Washington	District of Columbia	United States	20002

Sponsors and Collaborators

• University of Maryland

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• ClinicalTrials.gov Identifier: NCT01196312
• Other Study ID Numbers: DA023384
• First Posted: Sep 8, 2010
• Last Update Posted: Sep 8, 2010
• Last Verified: Sep 1, 2010

• Keywords provided by , ,: anxiety sensitivity; heroin
• Additional relevant MeSH terms: Anxiety Disorders

Study Results

No Results Posted as of Sep 8, 2010